The boxed warning
Ozempic, Wegovy, Mounjaro, and Zepbound all carry a black-box warning regarding thyroid C-cell tumors and contraindicate use in patients with a personal or family history of medullary thyroid cancer (MTC) or MEN-2 syndrome.
When you may have a claim
You may qualify if you were diagnosed with thyroid cancer (especially medullary) during or after GLP-1 use, with no prior personal or family history that contraindicated the drug.